| Table of Contents |
|---|
|
How Does the FEMA GRAS Program Meet the Requirements for GRAS? FEMA Expert Panel Conflict of Interest Protections and Procedures |
Introduction
In 1959, The Flavor and Extract Manufacturers Association of the United States (FEMA) took its initial actions to establish a novel program to assess the safety and “GRAS” (generally recognized as safe) status of flavor ingredients as described in the 1958 Food Additives Amendments to the Federal Food, Drug, and Cosmetic Act, the Federal law governing the regulation of flavors and other food ingredients. Since then, the FEMA GRAS program has become the longest-running and most widely recognized industry GRAS assessment program.
The FEMA GRAS program began in 1959 with a survey of the flavor industry to identify flavor ingredients then in use and to provide estimates of the amounts of these substances used to manufacture flavors. The initial FEMA Expert Panel was established in 1960 beginning the Expert Panel’s evaluation of the safety of flavor ingredients that continues today. Then and now, the Expert Panel usually consists of six to eight members and over the years has been comprised of top experts in toxicology, organic chemistry, biochemistry, metabolism, and pathology.
The FEMA Expert Panel’s GRAS assessments have from the beginning utilized a number of techniques now common in safety evaluations including the use of metabolic studies and structural relationships that had not previously been applied in a significant manner to food ingredients before the Panel did so in the 1960s in its evaluation of flavors. While the Expert Panel has been provided with financial support by FEMA it has always maintained its full independence in its operations and GRAS determinations and follows strict conflict of interest procedures.
The FEMA GRAS program is open to participation by Active Members of FEMA who may submit applications to the Expert Panel requesting consideration of flavor ingredients as generally recognized as safe.
Two publications by Hallagan and Hall (1995, 2009) provide a detailed review of the history of the FEMA GRAS Program, and its legal and scientific bases.
The GRAS Concept
In the United States, the GRAS concept is one way in which the regulatory authority to use a food ingredient (other than color additives) can be determined with the other key path being through an application to the Food and Drug Administration for food additive status. GRAS status may be achieved either through the FDA’s voluntary GRAS notification program (FDA, 1997) or through a properly conducted GRAS determination made by a private party. Section 201(s) of the Federal Food, Drug, and Cosmetic Act provides:
The term food additive means any substance the intended use of which results or may reasonably be expected to result, directly or indirectly, in its becoming a component or otherwise affecting the characteristics of any food . . . if such substance is not generally recognized, among experts qualified by training and experience to evaluate its safety as having been adequately shown through scientific procedures (or in the case of a substance used in food prior to January 1, 1958, through either scientific procedures or experience based on common use in food) to be safe under the conditions of intended use . . .
The statutory definition of GRAS has four key criteria, all of which must be met for a food ingredient to be considered generally recognized as safe and exempt from the requirements for food additive approval:
- There must be general recognition of safety by qualified experts.
- The experts must be qualified by training and experience to evaluate the substance’s safety.
- The experts must base their determination of safety on scientific procedures or on common use in food prior to 1958.
- The determination of general recognition of safety must take into account the conditions of intended use for the substance, in other words its function in the food, e.g. flavoring.
A key part of the requirements for GRAS status is that there must be general recognition of safety and not just an assertion of safety per se. This means that there must be an opportunity for interested parties to review the basis for GRAS determinations not just the conclusions. Detailed discussions of the requirements for determining GRAS status are available in Hallagan and Hall (1995, 2009) and the many references cited in these two publications.
How Does the FEMA GRAS Program Meet the Requirements for GRAS?
Qualified Experts
The mission of the FEMA Expert Panel is to protect the public health through the effective safety evaluation of flavor ingredients using the best available scientific procedures and information.
Over the years, members of the FEMA Expert Panel have included many prominent expert scientists. Most often, members of the FEMA Expert Panel are scientific experts from academia. Members of the Expert Panel have never been employees of FEMA member companies or employees of companies in the food industry. Current members of the FEMA Expert Panel are:
Dr. Nigel J. Gooderham, Ph.D. – Chair
Dept. of Metabolism, Digestion, Reproduction | Imperial College LondonScience
Nigel J. Gooderham, Ph.D, is Emeritus Professor of Molecular Toxicology in the Department of Metabolism, Digestion and Reproduction. Previously he held the position of Assistant Provost (Academic Promotions) at Imperial College London. He was a visiting professor at Kwame Nkrumah University of Science and Technology, Pharmacology, Kumasi, Ghana and University of Malaysia, Terangganu, Biochemistry, Terangganu, Malaysia.
Read Full Bio
Nigel’s research interests include mechanisms of chemical carcinogenesis and toxicity and the genetic toxicity of food-derived chemicals and oligonucleotides. His laboratory at Imperial has trained more than ninety postgraduate and postdoctoral researchers, many of whom now hold senior positions in academia, industrial, government and regulatory bodies. Nigel has also been actively involved in toxicology education at Imperial College London and externally, contributing primarily to postgraduate programs.
He was the founding Director of the MRes in Biomedical Research at Imperial. Nigel has served on numerous committees including the UK Government’s Advisory Committee on Mutagenicity, the MRC ITTP Steering Committee, Funding Panel and the NC3Rs Research Funding Assessment Panel and British Toxicology Society (BTS) Chairman of the Scientific Committee and member of the BTS Executive Board. He has been a member of the UK’s MHRA Panel of Assessors and has participated in a number of expert advisory panels on toxicology including medical devices, breast implants, plastic pollution, hair dyes, agricultural chemicals and pharmaceuticals. He was the founding Editor-in-Chief of Toxicology Research (published by the Royal Society of Chemistry) and has served on the Editorial Boards of Mutagenesis, Toxicology, the Journal of Applied Toxicology and the Cancer Handbook.
Nigel’s research contributions to international toxicology were recognized by EUROTOX (the European Societies of Toxicology) with the 2018 Bo Holmstedt Memorial Award. Nigel is a Gold Medal recipient and Fellow of the Royal Society of Chemistry and a Fellow of the British Toxicology Society (BTS), a member of the Society of Toxicology (USA), the Biochemical Society and the United Kingdom Environmental Mutagenicity Society. He has more than 264 publications in peer reviewed journals and over 7,000 citations.
Dr. Stephen S. Hecht, Ph.D. – Vice-Chair
Wallin Professor of Cancer Prevention Masonic Cancer Center and Dept. of Laboratory Medicine and Pathology | University of Minnesota
Stephen S. Hecht, Ph.D., is the Wallin Professor of Cancer Prevention in the University of Minnesota Department of Laboratory Medicine and Pathology. Dr. Hecht is an internationally recognized expert on cancer-causing agents in tobacco, has spent more than four decades studying how tobacco compounds enter the human body, get metabolized and damage DNA to cause lung cancer. His groundbreaking work in tobacco-specific carcinogens, known as nitrosamines (found in both cigarette smoke and smoke-less tobacco) helped provide a strong scientific basis for public policies restricting smoking, including clean indoor air laws, widely viewed as essential to tobacco control.
Read Full Bio
Dr. Hecht first demonstrated nitrosamine’s role in unburned tobacco in 1974 with his colleague, Dietrich Hoffman, Ph.D., a renowned cancer epidemiologist. Since then, he has worked towards further defining the impact on human health of many of the other 60 to 70 carcinogens found in cigarette smoke, and identifying which smokers face the greatest risk of developing lung cancer. The ability to identify susceptible smokers could lead to early interventional strategies that reduce the incidence and mortality from lung cancer.
A fellow of the American Association for the Advancement of Science since 2014, Dr. Hecht has received many honors. In 2006, he received the Excellence in Cancer Prevention Research award from the American Association for Cancer Research for his work on tobacco compounds and the pathways by which they cause cancer. He has received both a Merit Award and an Outstanding Investigator Grant from the National Cancer Institute. In 2012, he served as editor-in-chief of the American Chemical Society journal, Chemical Research in Toxicology. He has more than 800 publications in peer-reviewed journals and 45,000 citations.
Dr. F. Peter Guengerich, Ph.D.
Tadashi Inagami Professor of Biochemistry Dept. of Biochemistry | Vanderbilt University School of Medicine
Fred Peter Guengerich, Ph.D. is a renowned biochemist recognized for his significant contributions to the field of enzymology, particularly in the study of cytochrome P450 enzymes. He serves as a professor in the Department of Biochemistry at Vanderbilt University School of Medicine, where his research focuses on the metabolic activation of drugs and the biochemical mechanisms underlying drug metabolism and toxicity.
Read Full Bio
With a background in chemistry and biochemistry, Dr. Guengerich has published extensively in scientific journals, contributing to a greater understanding of how enzymes process xenobiotics and endogenous compounds.
Dr. Guengerich is also known for his involvement in mentorship and education, helping to train the next generation of scientists. His research has earned numerous accolades, establishing him as a leading figure in the fields of biochemistry and pharmacology. He has more than 600 publications in peer-reviewed journals and over 120,000 citations.
Dr. Gerhard Eisenbrand, Ph.D.
Senior Research Professor of Food Chemistry & Toxicology | University of Kaiserslautern, Germany (Retired)
Gerhard Eisenbrand, Ph.D., is Professor Emeritus at the University of Kaiserslautern, Department of Chemistry, Division of Food Chemistry and Toxicology.
Read Full Bio
He was long acting (1995 to 2013) chair of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG) and is currently Scientific President of ILSI Europe.
He mainly focuses on the mechanisms of action of genotoxicity and toxicity, various anticancer agents, metabolism and biokinetics, interactions of food constituents/contaminants with biomolecules in the organism, within the context of food safety and beneficial/adverse effects relevant to human health in experimental and human intervention studies.
He has more than 300 publications in peer-reviewed journals and over 10,000 citations.
Dr. Kumiko Ogawa, M.D., Ph.D.
Professor, Toxicology Laboratory Faculty of Pharmaceutical Sciences | Hoshi University
Kumiko Ogawa, M.D., Ph.D., is Professor in the Toxicology Laboratory at Hoshi University’s Faculty of Pharmaceutical Sciences. Her background includes long-standing leadership in pathology and toxicologic pathology at Japan’s National Institute of Health Sciences, where she served as Director of the Division of Pathology before joining Hoshi University. Dr. Ogawa’s research focuses on pathology, risk assessment, carcinogenesis, toxicologic pathology, experimental pathology, and the biological effects of chemical substances. Her work includes studies of chemical carcinogenesis, food and chemical safety, nanoparticle and nanomaterial toxicity, inhalation and oral toxicity assessment, and mechanisms of adverse effects associated with anticancer drugs.
Read Full Bio
She has contributed to research aimed at scientifically evaluating the toxicity of pharmaceuticals, industrial chemicals, pesticides, health foods, and other environmental chemicals, with emphasis on safe and appropriate use of useful chemical substances. Her laboratory also studies approaches for evaluating adverse biological effects from oral and inhalation exposure.
Dr. Ogawa has authored more than 260 peer-reviewed scientific papers and has contributed extensively to the literature on toxicology, toxicologic pathology, chemical carcinogenesis, and regulatory safety assessment.
Dr. Samuel M. Cohen, M.D., Ph.D.
Havlik–Wall Professor of Oncology, Dept. of Pathology, Microbiology and Immunology and Buffett Cancer | Center University of Nebraska Medical Center
Samuel M. Cohen, MD, PhD, is a professor in the UNMC Department of Pathology, Microbiology and Immunology, and is the Havlik-Wall Professor of Oncology.
Read Full Bio
He received his MD and PhD from the University of Wisconsin and served a pathology residency in pathology at St. Vincent Hospital in Worcester, Massachusetts. He served on the faculty of the University of Massachusetts Medical School until 1981, when he joined UNMC as professor in Pathology and Microbiology and in UNMC’s cancer center. He served as department vice chair from 1981-92, and as chair 1992-2007.
Dr. Cohen is active in surgical pathology, currently with a focus on gastrointestinal pathology. He served on the National Comprehensive Cancer Network panel for lower urinary tract tumors. He has been involved with basic research on chemical carcinogenesis, toxicology, and toxicologic pathology, having maintained an extramurally funded research program for almost 50 years.
Dr. Cohen serves on numerous national and international committees, including on the boards of Scientific Counselors for the National Toxicology Program of the National Institute of Environmental Health Sciences, and the Environmental Protection Agency Science Advisory Board. He has more than 480 publications in peer-reviewed journals and more than 50 chapters. He has over 30,000 citations.
Dr. Thomas J. Rosol, DVM, Ph.D., MBA
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine | Ohio University
Thomas Rosol, DVM, PhD, MBA is a professor of veterinary and toxicologic pathology, Chair of Biomedical Sciences at the Ohio University Heritage College of Osteopathic Medicine and diplomate of the American College of Veterinary Pathologists.
Read Full Bio
He has served as dean of the College of Veterinary Medicine and senior associate and interim vice president for research at Ohio State University and on advisory boards to the National Institutes of Health, United States Department of Agriculture, American Veterinary Medical Association, EPA, and Morris Animal Foundation.
The Rosol laboratory investigates the pathogenesis of animal models of human cancer, mechanisms and treatment of bone metastasis, and endocrine-responsive cancers. Recent work focuses on prostate, breast, head and neck cancer, and lymphoma. The laboratory specializes in molecular investigations and mouse and dog in vivo studies using state-of-the-art imaging using bioluminescence, microCT, high resolution ultrasound, MRI and PET.
Rosol is an elected fellow of the American Association for the Advancement of Science and was recognized by Ohio State University as a Distinguished Scholar, which is one of the universities highest honors. Rosol was awarded the Annual Distinguished Mentor Award from the Society of Toxicologic Pathologists (2015) and the ACVP Distinguished Member Award (2016). He has more than 300 publications in peer reviewed journals and over 16,000 citations.
Scientific Procedures to Determine Safety
As part of the FEMA GRAS program’s policy of transparency, the scientific criteria employed by the FEMA Expert Panel for its GRAS assessments are published in the peer-reviewed scientific literature so that they may be reviewed and understood by regulators, business, and the public. The current criteria for the GRAS assessment of single, chemically defined flavoring substances are described by Smith et al. (2005a). The current criteria for natural flavor complexes are described in Smith et al. (2004) and Smith et al. (2005b). The safety standard applied by the FEMA Expert Panel is the same standard required by FDA, a “reasonable certainty of no harm.”
Safety Under Conditions of Intended Use
The FEMA Expert Panel only evaluates substances for GRAS status that are used to formulate flavors to be added to human foods. The Expert Panel does not evaluate food ingredients with functions other than flavoring nor does it evaluate flavorings for use in products other than human food. For example, the Expert Panel does not evaluate flavor ingredients for use in tobacco products, e-cigarettes, or other products that involve routes of exposure other than ingestion.
General Recognition of Safety
The general recognition requirement for GRAS status is perhaps the most important factor. The Expert Panel and the FEMA GRAS program meet this requirement in a number of ways:
- The Expert Panel is generally composed of six to eight members of various scientific disciplines. This provides a high degree of confidence that decisions made by the Panel are consistent with current scientific concepts and that the decisions would be generally recognized as scientifically appropriate.
- The scientific criteria employed by the FEMA Expert Panel for its GRAS assessments are published in the peer-reviewed scientific literature so that they may be reviewed and understood by regulators, business, and the public. (Smith et al., 2004; Smith et al., 2005; Cohen et al., 2018).
- The identity of all FEMA GRAS substances is published in several ways. Lists of FEMA GRAS flavor ingredients are published regularly in the widely-read food industry journal, Food Technology. The identity of all FEMA GRAS substances is also available on the FEMA website (www.femaflavor.org). This ready availability of information provides the public with notice of FEMA GRAS determinations allowing for challenges to the Expert Panel’s conclusions.
- The scientific information serving as the basis for the Expert Panel’s determinations of GRAS status is provided to FDA for all FEMA GRAS flavor ingredients. This allows the agency to include the information in its databases and to challenge any GRAS determinations that it wishes. It is important to note that the receipt by FDA of the information provided by FEMA does not constitute FDA’s “approval” of the GRAS determinations made by the FEMA Expert Panel.
- Descriptions of the scientific information supporting the GRAS status of individual flavor ingredients are published in the “FEMA group summaries” in which information on individual flavoring substances and their structural relatives is reviewed. These summaries are published in the widely-read toxicology journal Food and Chemical Toxicology.
- Group summaries on approximately 2,200 FEMA GRAS flavoring substances have also been published by the Joint FAO/WHO Expert Committee on Food Additives (JECFA), an international scientific advisory body managed through the United Nations (See http://www.who.int/foodsafety/areas_work/chemical-risks/jecfa/en/).
- Scientific Literature Reviews (SLRs) published by the National Technical Information Service (NTIS), a federal government agency, provide a large amount of information relevant to the safety of FEMA GRAS flavor ingredients up through the late 1980s.
- FEMA publishes detailed reviews on the safety of individual flavoring substances to address specific issues.
In addition to the multiple sources of published information listed above, FEMA’s policy is to share information on all FEMA GRAS substances with anyone upon request. For example, if a person wants to question or challenge the status of a FEMA GRAS substance the person may obtain from FEMA all of the available information used to determine that the substance is GRAS under its conditions of intended use as a flavor ingredient.
Additional support to meet the general recognition requirement is FDA’s acknowledgment in Federal Register notices that FEMA GRAS substances were “approved for inclusion in the FDA GRAS review process” and therefore were eligible for the application of its bulk flavor labeling policy. (41 Fed. Reg. 4954. 3 February 1976). FDA’s 1976 notice explicitly accounted for “FEMA GRAS lists 3 through 9.” (41 Fed. Reg. 4954. 3 February 1976). Subsequent notices accounted for new FEMA GRAS substances as follows:
- “GRAS 10” – 42 Fed. Reg. 55643. 18 October 1977
- “GRAS 11” – 43 Fed. Reg. 22784. 26 May 1978
- “GRAS 12” – 44 Fed. Reg. 71460. 11 December 1979
FDA published its last notice in 1979 due to a change in agency priorities.
FEMA Expert Panel Conflict of Interest Protections and Procedures
A number of measures are in place to assure that Expert Panel decisions on GRAS status are fully objective and based solely on the merits of the available information and are not subject to bias.
- FEMA Expert Panel members are not allowed to have consulting relationships with FEMA member companies regarding anything to do with flavors in the context of the FEMA GRAS Program.
- FEMA Expert Panel members provide a declaration of their consulting and business relationships prior to each Expert Panel meeting for review and action, if necessary, by the Panel’s Legal Advisor. Action may include mandated recusal at meetings.
- FEMA Expert Panel members do not prepare GRAS applications. Applications for FEMA GRAS assessments are prepared by the FEMA member seeking the GRAS assessment for the substance at issue.
- When evaluating GRAS applications, Expert Panel members do not know the identity of the company responsible for the application. The identity of applicant-companies is maintained as confidential information by the FEMA staff even after the substance is evaluated and granted GRAS status.
- Companies submitting GRAS applications are not allowed to contact Expert Panel members in any way nor are they allowed to attend meetings during which their applications are being considered.
- The identity of the members of the Expert Panel is known to the public through their regular publications in Food Technology, Food and Chemical Toxicology, and other publicly available journals.
- The Expert Panel is self-appointed – members are not appointed by FEMA. When a member retires from the Panel, the retiring member recommends a successor whose qualifications are reviewed by the remaining Expert Panel members who make the appointment.
- FEMA Expert Panel members conduct their reviews of GRAS applications during in-person meetings, usually three times per year and receive an honorarium for their service whether or not they conclude that any substances are GRAS.
- FEMA staff members are not allowed to have independent consulting or business relationships with FEMA member companies regarding anything to do with flavors in the context of the FEMA GRAS program.
The FEMA GRAS Program and Transparency
The FEMA GRAS program meets the highest standards for transparency. All GRAS determinations made by the FEMA Expert Panel are provided to FDA along with the scientific information supporting the determinations. It is important to note that the receipt by FDA of the information provided by FEMA does not constitute FDA’s “approval” of the GRAS determinations made by the FEMA Expert Panel. The identities of all flavor ingredients determined to be GRAS are published regularly in the widely read journal Food Technology. The scientific basis for the Expert Panel’s GRAS determinations including detailed summaries of the supporting scientific information are published in widely read scientific journals including Food and Chemical Toxicology. Extensive summaries of the information supporting the safety of FEMA GRAS substances are also published by the Joint FAO/WHO Expert Committee on Food Additives (JECFA), an independent international scientific advisory body managed through the United Nations (See http://apps.who.int/food-additives-contaminants-jecfa-database/search.aspx).
A significant additional transparency measure is that anyone wishing to review the scientific information supporting the GRAS status of any FEMA GRAS flavor ingredient may request the information from FEMA and receive it for only the cost of duplication.
Evidence of the high degree of transparency of the FEMA GRAS program can be found in a list of more than two hundred individual publications describing the FEMA GRAS program and the safety of flavor ingredients. This list is available upon request from FEMA.
In conclusion, the FEMA GRAS program meets the highest standards for transparency and in doing so provides a high level of assurance in its GRAS determinations for flavor ingredients.
For more information on the FEMA GRAS program please contact John Hallagan – FEMA Senior Advisor and General Counsel ([email protected]) or Sean Taylor – Scientific Secretary to the FEMA Expert Panel ([email protected]).
References
- Food and Drug Administration. Substances generally recognized as safe. 62 Fed. Reg. 18938. 17 April 1997.
- Hallagan J.B. and Hall R.L. FEMA GRAS – A GRAS assessment program for flavor ingredients. Regulatory Toxicology and Pharmacology. 21, 422. 1995.
- Hallagan J.B. and Hall R.L. Under the conditions of intended use – New developments in the FEMA GRAS program and the safety assessment of flavor ingredients. Food and Chemical Toxicology. 47, 267. 2009.
- Smith R.L., Adams T.B., Cohen S.M., Doull J., Feron V.J., Goodman J.I., Hall R.L., Marnett L.J., Waddell W.J., and Wagner B.M. Safety evaluation of natural flavor complexes. Toxicology Letters. 149, 197. 2004.
- Smith R.L., Cohen S.M., Doull J., Feron V.J., Goodman J.I., Marnett L.J., Munro I.C., Portoghese P.S., Waddell W.J., Wagner B.M., and Adams T.B., Criteria for the safety evaluation of flavoring substances. Food and Chemical Toxicology. 43, 1141. 2005.
- Cohen S.M., Eisenbrand G.E., Fukushima S.F., Gooderham N.J., Guengerich F.P., Hecht S.S., Rietjens I.M.C.M., Davidsen J.M., Harman C.L., Taylor S.V. Updated procedure for the safety evaluation of natural flavor complexes used as ingredients in food. Food and Chemical Toxicology. 113, 171. 2018.
References available from FEMA upon request.